Table 5.
(A) 68Ga-PSMA-11 PET/CT positivity rate (RP) of different subgroups related to PSA levels. (B) 68Ga-PSMA-11 PET/CT positivity rate (RT) of different subgroups that were related to PSA levels.
| (A) 68Ga-PSMA-11 PET/CT positivity rate (RP) of different subgroups related to PSA levels. | ||||||
| PSA Range (ng/mL) | Overall Positivity | p/r Value | Single Metastases | Multiple Metastases | p/r Value | |
| 0.2 to <1 (145) | 75 (51.7%) | 28 (19.3%) | 33 (22.8%) | |||
| <1.24 (177) | 92 (52%) | 33 (31%) | 44 (21%) | |||
| ≥1.24 (316) | 278 (87.4%) | 72 (69%) | 164 (79%) | |||
| Total (493) | 370 (75%) | p < 0.001: r 0.400 | 105 | 208 | p < 0.001: r 0.315 | |
| PSA Range (ng/mL) | Local Recur-Rence | p/r Value | Local Metastases | Distant Metastases | Local + Distant Metastases | p/r Value |
| 0.2 to <1 (145) | 20 (13.8%) | 44 (30.3%) | 10 (6.9%) | 7 (4.8%) | ||
| <1.24 (177) | 23 (13%) | 51 (28.8%) | 15 (8.5%) | 11 (6.2%) | ||
| ≥1.24 (316) | 86 (27.2%) | 118 (37.3%) | 56 (17.7%) | 62 (19.6%) | ||
| Total (493) | 109 | p < 0.001; r 0.164 | 169 | 71 | 73 | p < 0.001; r 0.308 |
| (B) 68Ga-PSMA-11 PET/CT positivity rate (RT) of different subgroups that were related to PSA levels. | ||||||
| PSA Range (ng/mL) | Overall Positivity | p/r Value | Single Metastases | Multiple Metastases | p/r Value | |
| <5.75 (36) | 31 (86.1%) | 15 (41.7%) | 19 (52.8%) | |||
| ≥5.75 (52) | 49 (94.2%) | 7 (13.5%) | 29 (55.8%) | |||
| Total (88) | 80 (91%) | p = 0.19; r 0.139 | 22 | 48 | p = 0.008; r 0.255 | |
| PSA Range (ng/mL) | Local Recur-Rence | p/r Value | Local Metastases | Distant Metastases | Local + Distant Metastases | p/r Value |
| <5.75 (36) | 22 (61.1%) | 11 (30.6%) | 1 (2.8%) | 4 (11.1%) | ||
| ≥5.75 (52) | 28 (53.8%) | 11 (21.2%) | 13 (25%) | 11 (21.2%) | ||
| Total (88) | 50 | p = 0.5; r −0.07 | 22 | 14 | 15 | p = 0.01; r 0.286 |
Abbreviations: PSA, prostate-specific-antigen; p < 0.05 is considered significant; r, Pearson correlation coefficient.